Patriot Financial Group Insurance Agency, LLC Alkermes Plc. Transaction History

Patriot Financial Group Insurance Agency, LLC

$720 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 15, 2021	SELL	$15.39 - $22.1 $153 - $221	-10 Closed	0 $0
Q3 2020 Oct 21, 2020	BUY	$16.16 - $20.66 $161 - $206	10 New	10 $0
Q4 2019 Jan 22, 2020	SELL	$17.29 - $21.74 $4,599 - $5,782	-266 Closed	0 $0
Q3 2018 Oct 30, 2018	BUY	$38.6 - $46.12 $10,267 - $12,267	266 New	266 $11,000

Others Institutions Holding ALKS

# of Institutions

360

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

Black Rock Inc. New York, NY

29.1M
Shares

$821 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$535 Million
0.01% of portfolio
Price T Rowe Associates Inc Baltimore, MD

13M
Shares

$366 Million
0.04% of portfolio
Wellington Management Group LLP Boston, MA

12.7M
Shares

$357 Million
0.06% of portfolio
State Street Corp Boston, MA

9.19M
Shares

$259 Million
0.01% of portfolio

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.63B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Account